TreeHouse Health Announces Thirteenth Portfolio Company, StemoniX

Share Article

TreeHouse Health adds Stemonix as thirteenth Portfolio Company in the ecosystem.

We’re confident our relationship with TreeHouse Health will help us establish a strong presence in Minnesota, as well as generate new opportunities for […] financing and collaborative partnerships with TreeHouse Health [...] connections.

TreeHouse Health, an innovation center designed to invest in emerging healthcare companies and help accelerate their growth, adds thirteenth Portfolio Company, StemoniX, a biotechnology company that is setting a new standard for stem cell technologies to meet the demands of drug discovery and personalized medicine.

“We are excited to announce the addition of StemoniX to the TreeHouse Health ecosystem. Through their innovative work, they are advancing the field of drug discovery and ultimately helping patients get better treatment more quickly,” J.D. Blank, Managing Director, TreeHouse Health.

StemoniX is revolutionizing the pharmaceutical industry with its stem cell technologies. StemoniX technologies provide the ability to create a variety of organ cells that can mimic diseases to help accelerate the discovery of new cures in the areas of heart disease, dementia and neuromuscular diseases. This is done by growing, differentiating, shaping and printing organ cells from skin cells, in a way that makes them biologically accurate, to better predict drug toxicity and efficacy.

StemoniX was recently recognized as one of today’s most innovative and market changing businesses, earning the Grand Prize and title of Best Breakthrough Business Idea of 2016 at the 12th annual MN Cup awards. This recognition adds to the award StemoniX received in August for winning the Life Science/ Health IT Division of this competition.

“StemoniX is grateful to become part of TreeHouse Health as a portfolio company,” said Ping Yeh, CEO of StemoniX. “We’re confident our relationship with TreeHouse Health will help us establish a strong presence in Minnesota, as well as generate new opportunities for Minnesota-based financing and collaborative partnerships with TreeHouse Health Anchor Tenants and other connections. We are thankful to the MN Cup organizers, sponsors, and community for their support and the opportunities created by our participation in the competition this year, which includes our new relationship with TreeHouse Health.”

Along with providing investment, TreeHouse Health also offers its portfolio companies access to its ecosystem consisting of leading healthcare organizations, professional service providers, and other emerging healthcare companies.

About TreeHouse Health LLC
TreeHouse Health, established in 2013, is an innovation center that helps emerging healthcare companies accelerate their growth by facilitating collaboration with Anchor Tenants while simultaneously providing investment, expertise and guidance around business development and brand exposure. To date, TreeHouse Health has invested in thirteen early-stage healthcare companies and has three Anchor Tenant relationships with Hennepin County Medical Center (HCMC), Blue Cross and Blue Shield of Minnesota (BCBS), and Accenture. To learn more, visit

About StemoniX
StemoniX is leading the development and manufacturing of human induced pluripotent stem cells for pharmaceutical drug discovery applications, such as biologically accurate, miniaturized organ-like microtissues. Its biotechnology provides scientists with standardized, easy-to-use, cost-effective access to relevant human microtissue for toxicity and efficacy screening. Incorporated in Minnesota, the company is co-located in Minneapolis and San Diego, California. For more information, visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Holly Janiszewski

Ryan Gordon
Email >
since: 09/2013
Follow >
Visit website